As specialty pharmaceuticals are prescribed more frequently to treat more common diseases, the number of them under development and expected to be approved by the FDA in the next several years is surpassing that of other categories of drugs.
Research advances sparked by the Human Genome Project may soon significantly affect the practice, prescription and production of medicine.
New research comparing the new Fluzone High-Dose vaccine and the seasonal flu vaccine sheds light on how ineffective the latter vaccine has been for the elderly.
With the leading edge of the baby boom generation set to double the over-65 population during the next 20 years,Alzheimer’s has long been a leading target for development of potentially disease-modifying drugs.
An epidemic of pertussis in California — of a size not seen in some 50 years — makes educating the public about this disease and how to prevent it more important than ever.
With millions of people dying annually worldwide from pneumonia, the facts about who is at risk of contracting this disease and how it can be prevented have never been more important.
From identifying the strain to prioritizing high-risk recipients, a look at lessons learned from the development and distribution of the H1N1 vaccine.
Vaccines to treat pre-existing conditions have the potential to radically change medical treatment, and there’s renewed hope that therapeutic vaccines might soon be available to treat various diseases.
The search for a preventive and therapeutic vaccine for HIV has long been studied. A look at past and current research shows just how far we’ve come.
Scientists are working on a variety of molecular and imaging diagnostics to advance the early detection rate of cancer.
A behind-the-scenes look at what goes into a successful flu immunization clinic, whether it’s large or small.
New options in immune globulin therapy give patients more options for receiving this gold-standard treatment.